Combustion is the problem with smoking. Burning plant material at around 900 degrees Celsius creates hundreds of compounds that were not in the plant, including tar, carbon monoxide and polycyclic aromatic hydrocarbons.
Vaporising heats cannabis to roughly 180 to 210 degrees Celsius, enough to release cannabinoids and terpenes as vapour without igniting the material. That is a genuine difference, and it is not the same as being safe.
What Vaporising Removes
Vaporising is also more efficient, extracting more cannabinoid per unit of material, so you get more effect from less flower. That is a cost and a dosing consideration as much as a health one.
What Vaporising Does Not Change
The EVALI Lesson
In 2019 a wave of serious lung injury appeared among people using vaping products, and it was widely reported as evidence that vaping cannabis is dangerous. The actual finding is more specific and more useful.
Investigation traced the outbreak substantially to vitamin E acetate, used as a thickening or cutting agent in illicit-market THC cartridges. It was largely absent from tested, regulated products.
Vitamin E acetate is harmless when swallowed and damaging when inhaled into the lungs, which is exactly the kind of failure that unregulated manufacturing produces.
So EVALI is a supply chain story rather than a verdict on vaporisation. The practical lesson is to buy tested cartridges from licensed sources, which is the same lesson every cannabis safety topic arrives at.
Dry Herb Versus Cartridges
These are different products with different risk profiles, and lumping them together causes confusion.
Dry herb vaporisers heat actual flower. You know what is in it, temperature is adjustable, and there are no added ingredients. Temperature affects the result: lower settings around 180 degrees Celsius favour terpenes and flavour with lighter effects, higher settings around 200 to 210 degrees Celsius extract more cannabinoid with harsher vapour.
Cartridges contain concentrated oil, usually distillate with terpenes added back. Additional concerns apply:
The Honest Uncertainty
Long-term respiratory data on cannabis vaporisation is limited. The technology is recent relative to the timescales over which lung disease develops, so the absence of long-term harm findings reflects an absence of long-term studies rather than a demonstrated safety record.
Comparisons with nicotine vaping are also imperfect, since the devices, temperatures and inhaled substances differ.
Practical Guidance
Bottom Line
Vaporising avoids combustion and therefore avoids carbon monoxide, tar and polycyclic aromatic hydrocarbons, and users report fewer respiratory symptoms. It does not change cardiovascular, cognitive or dependence effects. EVALI was caused by vitamin E acetate in illicit cartridges rather than by vaporisation, and long-term data remains genuinely thin.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before making any health-related decisions.
